Cognitive behavioral therapy for psychogenic nonepileptic seizures


      Treatment trials for psychogenic nonepileptic seizures (PNES) are few, despite the high prevalence and disabling nature of the disorder. We evaluated the effect of cognitive behavioral therapy (CBT) on reduction of PNES. Secondary measures included psychiatric symptom scales and psychosocial variables. We conducted a prospective clinical trial assessing the frequency of PNES in outpatients treated using a CBT for PNES manual. Subjects diagnosed with video/EEG-confirmed PNES were treated with CBT for PNES conducted in 12 weekly sessions. Seizure calendars were charted prospectively. Twenty-one subjects enrolled, and 17 (81%) completed the CBT intervention. Eleven of the 17 completers reported no seizures by their final CBT session. Mean scores on scales of depression, anxiety, somatic symptoms, quality of life, and psychosocial functioning showed improvement from baseline to final session. CBT for PNES reduced the number of PNES and improved psychiatric symptoms, psychosocial functioning, and quality of life.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gardner J.E.
        Behavior therapy treatment approach to a psychogenic seizure case.
        J Consult Psychol. 1967; 31: 209-212
        • LaFrance Jr, W.C.
        • Devinsky O.
        The treatment of nonepileptic seizures: historical perspectives and future directions.
        Epilepsia. 2004; 45: 15-21
        • LaFrance Jr, W.C.
        • Barry J.J.
        Update on treatments of psychological nonepileptic seizures.
        Epilepsy Behav. 2005; 7: 364-374
        • Brooks J.L.
        • Goodfellow L.
        • Bodde N.M.
        • Aldenkamp A.
        • Baker G.A.
        Nondrug treatments for psychogenic nonepileptic seizures: what’s the evidence?.
        Epilepsy Behav. 2007; 11: 367-377
        • LaFrance Jr, W.C.
        • Alper K.
        • Babcock D.
        • et al.
        Nonepileptic seizures treatment workshop summary.
        Epilepsy Behav. 2006; 8: 451-461
        • Kroenke K.
        • Swindle R.
        Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials.
        Psychother Psychosom. 2000; 69: 205-215
        • Sumathipala A.
        • Hewege S.
        • Hanwella R.
        • Mann A.H.
        Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: a feasibility study in Sri Lanka.
        Psychol Med. 2000; 30: 747-757
        • Butler A.C.
        • Chapman J.E.
        • Forman E.M.
        • Beck A.T.
        The empirical status of cognitive-behavioral therapy: a review of meta-analyses.
        Clin Psychol Rev. 2006; 26: 17-31
        • Goldstein L.H.
        • Deale A.C.
        • Mitchell-O’Malley S.J.
        • Toone B.K.
        • Mellers J.D.C.
        An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study.
        Cogn Behav Neurol. 2004; 17: 41-49
        • Reiter J.
        • Andrews D.
        • Janis C.
        Taking control of your epilepsy: a workbook for patients and professionals.
        The Basics, Santa Rosa, CA1987
        • Reiter J.M.
        • Andrews D.J.
        A neurobehavioral approach for treatment of complex partial epilepsy: efficacy.
        Seizure. 2000; 9: 198-203
        • Greenberger D.
        • Padesky C.A.
        Mind over mood: change how you feel by changing the way you think.
        Guilford Press, New York1995
        • Prueter C.
        • Schultz-Venrath U.
        • Rimpau W.
        Dissociative and associated psychopathological symptoms in patients with epilepsy, pseudoseizures, and both seizure forms.
        Epilepsia. 2002; 43: 188-192
        • Hixson J.D.
        • Balcer L.J.
        • Glosser G.
        • French J.A.
        Fear sensitivity and the psychological profile of patients with psychogenic nonepileptic seizures.
        Epilepsy Behav. 2006; 9: 587-592
        • LaFrance Jr, W.C.
        • Devinsky O.
        Treatment of nonepileptic seizures.
        Epilepsy Behav. 2002; 3: S19-S23
        • Beck A.T.
        Cognitive therapy and the emotional disorders.
        Intl. Univ. Press, New York1976
        • Beck J.S.
        Cognitive therapy: basics and beyond.
        Guilford Press, New York1995
        • LaFrance W.C.
        How many patients with psychogenic nonepileptic seizures also have epilepsy?.
        Neurology. 2002; 58: 990-991
        • Rief W.
        • Nanke A.
        • Emmerich J.
        • Bender A.
        • Zech T.
        Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior.
        J Psychosom Res. 2004; 57: 367-371
        • Fink P.
        • Rosendal M.
        • Toft T.
        Assessment and treatment of functional disorders in general practice: the extended reattribution and management model—an advanced educational program for nonpsychiatric doctors.
        Psychosomatics. 2002; 43: 93-131
        • Goldberg D.
        • Gask L.
        • O’Dowd T.
        The treatment of somatization: teaching techniques of reattribution.
        J Psychosom Res. 1989; 33: 689-695
        • Morriss R.
        • Gask L.
        • Ronalds C.
        • et al.
        Cost-effectiveness of a new treatment for somatized mental disorder taught to GPs.
        Fam Pract. 1998; 15: 119-125
        • Morriss R.K.
        • Gask L.
        Treatment of patients with somatized mental disorder: effects of reattribution training on outcomes under the direct control of the family doctor.
        Psychosomatics. 2002; 43: 394-399
        • Mohr D.C.
        • Hart S.L.
        • Julian L.
        • et al.
        Telephone-administered psychotherapy for depression.
        Arch Gen Psychiatry. 2005; 62: 1007-1014
        • Mohr D.C.
        • Hart S.
        • Vella L.
        Reduction in disability in a randomized controlled trial of telephone-administered cognitive-behavioral therapy.
        Health Psychol. 2007; 26: 554-563
        • Vallis T.M.
        • Shaw B.F.
        • Dobson K.S.
        The Cognitive Therapy Scale: psychometric properties.
        J Consult Clin Psychol. 1986; 54: 381-385
        • Beck A.T.
        • Steer R.A.
        • Brown G.K.
        Manual for the Beck depression inventory.
        2nd ed. (BDI–II). Psychological Corp., San Antonio1996
        • Miller I.W.
        • Bishop S.
        • Norman W.H.
        • Maddever H.
        The Modified Hamilton Rating Scale for Depression: reliability and validity.
        Psychiatry Res. 1985; 14: 131-142
        • Davidson J.
        Davidson Trauma Scale.
        Multi-Health Systems, Inc., New York1996
        • Bernstein E.M.
        • Putnam F.W.
        Development, reliability, and validity of a dissociation scale.
        J Nerv Ment Dis. 1986; 174: 727-735
        • Barratt E.S.
        • Stanford M.S.
        • Kent T.A.
        • Felthous A.
        Neuropsychological and cognitive psychophysiological substrates of impulsive aggression.
        Biol Psychiatry. 1997; 41: 1045-1061
        • Epstein N.B.
        • Baldwin L.M.
        • Bishop D.S.
        The McMaster family assessment device.
        J Marital Fam Ther. 1983; 9: 171-180
        • Ryan C.E.
        • Epstein N.B.
        • Keitner G.I.
        • Miller I.W.
        • Bishop D.S.
        Evaluating and treating families: the McMaster approach.
        Routledge, New York2005
        • Derogatis L.R.
        • Lipman R.S.
        • Covi L.
        SCL-90: an outpatient psychiatric rating scale—preliminary report.
        Psychopharmacol Bull. 1973; 9: 13-28
        • Endicott J.
        • Spitzer R.L.
        • Fleiss J.L.
        • Cohen J.
        The global assessment scale: procedure for measuring overall severity of psychiatric disturbance.
        Arch Gen Psychiatry. 1976; 33: 766-771
        • Bamford J.M.
        • Sandercock P.A.
        • Warlow C.P.
        • Slattery J.
        Interobserver agreement for the assessment of handicap in stroke patients.
        Stroke. 1989; 20: 828
        • Leon A.C.
        • Solomon D.A.
        • Mueller T.I.
        • Turvey C.L.
        • Endicott J.
        • Keller M.B.
        The range of impaired functioning tool (LIFE-RIFT): a brief measure of functional impairment.
        Psychol Med. 1999; 29: 869-878
        • Vitaliano P.P.
        • Russo J.
        • Carr J.E.
        • Maiuro R.D.
        • Becker J.
        The ways of coping checklist: revision and psychometric properties.
        Multivariate Behav Res. 1985; 20: 3-26
      1. Vickrey B.G. Perrine K.R. Hays R.D. Quality of life in epilepsy: QOLIE-31—scoring manual. Version 1.0 ed. Rand, Santa Monica, CA1993
        • Rief W.
        • Barsky A.J.
        Psychobiological perspectives on somatoform disorders.
        Psychoneuroendocrinology. 2005; 30: 996-1002
        • Chalder T.
        Non-epileptic attacks: a cognitive behavioral approach in a single case with a four-year follow-up.
        Clin Psychol Psychother. 1996; 3: 291-297
        • Goldstein L.H.
        • Mellers J.D.
        Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures.
        J Neurol Neurosurg Psychiatry. 2006; 77: 616-621
        • Vlaeyen J.W.
        • Linton S.J.
        Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art.
        Pain. 2000; 85: 317-332
        • Stiles T.C.
        • Wright D.
        Cognitive-behavioural treatment of chronic pain conditions.
        Nord J Psychiatry. 2008; 62: 30-36
        • Zimmerman M.
        • Chelminski I.
        • Posternak M.A.
        Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included.
        J Nerv Ment Dis. 2004; 192: 87-94
        • Keitner G.I.
        • Posternak M.A.
        • Ryan C.E.
        How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial?.
        J Clin Psychiatry. 2003; 64: 1091-1093
        • Reuber M.
        • Mitchell A.J.
        • Howlett S.
        • Elger C.E.
        Measuring outcome in psychogenic nonepileptic seizures: how relevant is seizure remission?.
        Epilepsia. 2005; 46: 1788-1795
        • Krawetz P.
        • Fleisher W.
        • Pillay N.
        • Staley D.
        • Arnett J.
        • Maher J.
        Family functioning in subjects with pseudoseizures and epilepsy.
        J Nerv Ment Dis. 2001; 189: 38-43
        • Aboukasm A.
        • Mahr G.
        • Gahry B.R.
        • Thomas A.
        • Barkley G.L.
        Retrospective analysis of the effects of psychotherapeutic interventions on outcomes of psychogenic nonepileptic seizures.
        Epilepsia. 1998; 39: 470-473
        • Reuber M.
        • Pukrop R.
        • Bauer J.
        • Helmstaedter C.
        • Tessendorf N.
        • Elger C.E.
        Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients.
        Ann Neurol. 2003; 53: 305-311
        • West E.D.
        • Jackson A.
        • Physentides A.
        • et al.
        Randomized comparative trial of a ward discussion group.
        Br J Psychiatry. 1982; 141: 76-80
      2. LaFrance Jr WC, Blum AS, Ryan CE, Miller IW, Keitner GI. Abstract P07.012. Comorbidities in patients with psychogenic nonepileptic seizures. Neurology 2009; in press.

        • LaFrance Jr, W.C.
        • Rusch M.D.
        • Machan J.T.
        What is “treatment as usual” for nonepileptic seizures?.
        Epilepsy Behav. 2008; 12: 388-394